TSLPR deficiency attenuates AHR independently of eosinophilia and mucus secretion in a chronic HDM mouse model of allergic asthma
PLOS One · 2025
DOI: 10.1371/journal.pone.0335742 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Latifa Koussih und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada. Hauptthemen laut MEDLINE: Asthma, Mucus, Eosinophilia. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research.
Abstract (Originalsprache)
Background
Asthma is marked by chronic airway inflammation, immune dysregulation, and airway remodeling. While TSLP is known to influence allergic diseases like asthma, the role of TSLPR in airway remodeling is not well-defined.
Methods
Using TSLPR-deficient (TSLPR -/- ) mice in a chronic HDM asthma model, we assessed lung function, inflammatory cell infiltration, cytokine levels, and antibody production in serum and lung tissues. Airway remodeling was evaluated by examining mucus production, goblet cell metaplasia, and collagen deposition.
Results
TSLPR -/- mice showed lower airway resistance, tissue resistance, and tissue elastance compared to wild-type mice after chronic HDM exposure. TSLPR -/- mice also had reduced HDM-specific IgE levels and decreased IL-4, IL-13, and IFN-γ in BALF. However, airway and lung inflammation, including inflammatory cell counts and eosinophil infiltration, were similar between TSLPR -/- and WT mice. Collagen deposition, mucus production, and goblet cell changes were also comparable.
Conclusion
TSLPR deficiency reduced airway hyperresponsiveness but did not significantly impact lung eosinophil and neutrophil counts or mucus and collagen production in a chronic HDM asthma model, highlighting the complex role of TSLP and TSLPR in severe asthma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
- Departement de Biologie Experimentale, Université de Saint Boniface, Winnipeg, Manitoba, Canada.
- Department of Physiology and Pathophysiology, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
- Laboratoire d'Immunologie et de Biotechnologie, UR7509-IRMAIC, UFR de Pharmacie, Pôle-Santé, Université de Reims Champagne-Ardenne, Reims, France.
ORCID-Profile: Abdelilah S Gounni
Förderung
- Canadian Institutes of Health Research
Zitieren
APA
Koussih, L., Taefehshokr, S., Shan, L., Basu, S., Halayko, A., Lamkhioued, B., & Gounni, A. S. (2025). TSLPR deficiency attenuates AHR independently of eosinophilia and mucus secretion in a chronic HDM mouse model of allergic asthma. PLOS One. https://doi.org/10.1371/journal.pone.0335742
Vancouver
Koussih L, Taefehshokr S, Shan L, Basu S, Halayko A, Lamkhioued B, et al. TSLPR deficiency attenuates AHR independently of eosinophilia and mucus secretion in a chronic HDM mouse model of allergic asthma. PLOS One. 2025. doi:10.1371/journal.pone.0335742
BibTeX
@article{Koussih2025,
author = {Koussih, Latifa and Taefehshokr, Sina and Shan, Lianyu and Basu, Sujata and Halayko, Andrew and Lamkhioued, Bouchaib and Gounni, Abdelilah S},
title = {TSLPR deficiency attenuates AHR independently of eosinophilia and mucus secretion in a chronic HDM mouse model of allergic asthma},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0335742}
}
EUVIMED